JAAD Game Changer: A phase 2 study of oral difelikefalin in subjects with chronic kidney disease and moderate-to-severe pruritus
Journal of the American Academy of Dermatology · 2026-09 · 95 (3) · 929
DOI: 10.1016/j.jaad.2026.06.040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2026-09. Verfasst von Robert T Brodell. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Brodell, R. T. (2026). JAAD Game Changer: A phase 2 study of oral difelikefalin in subjects with chronic kidney disease and moderate-to-severe pruritus. Journal of the American Academy of Dermatology, 95(3), 929. https://doi.org/10.1016/j.jaad.2026.06.040
Vancouver
Brodell RT. JAAD Game Changer: A phase 2 study of oral difelikefalin in subjects with chronic kidney disease and moderate-to-severe pruritus. Journal of the American Academy of Dermatology. 2026;95(3):929. doi:10.1016/j.jaad.2026.06.040
BibTeX
@article{Brodell2026,
author = {Brodell, Robert T},
title = {JAAD Game Changer: A phase 2 study of oral difelikefalin in subjects with chronic kidney disease and moderate-to-severe pruritus},
journal = {Journal of the American Academy of Dermatology},
year = {2026},
volume = {95},
number = {3},
pages = {929},
doi = {10.1016/j.jaad.2026.06.040}
}
EUVIMED